Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087202856> ?p ?o ?g. }
- W3087202856 endingPage "115" @default.
- W3087202856 startingPage "106" @default.
- W3087202856 abstract "Background Aberrations in TP53, PTEN and RB1 are key drivers of therapy resistance in prostate cancer. Up to 50% of prostate cancers harbor ETS gene rearrangements, a potentially compounding aggressive biological event. Little is known about the impact of aggregate aberrations and gene fusion events in prostate cancer. Methods Using cBioportal for Cancer Genomics, an open-access resource for exploration of multidimensional genomics data, we integrate whole-exome sequencing, gene expression, and histopathology with longitudinal clinical outcomes. Subsets of prostate tumors with aberrations in all three genes TP53, PTEN and RB1 were identified and correlated with prevalence of gene fusions. Prostate tumors with aberrations in TP53, PTEN, and RB1 were termed triple aberrant prostate cancer (TAPC). Results Of 479 metastatic prostate tumors, 195 (40.7%) were TAPC, versus 21 of 594 (3.5%) of primary prostate tumors. Patients with metastatic TAPC showed a trend toward poorer overall survival than patients harboring 0, 1 or 2 of these aberrations. Twenty-five distinct fusions were identified, all involving ETS transcription factors. Both primary and metastatic prostate cancers with ETS fusions were significantly more likely to be TAPC than those without ETS fusions. Conclusions This study identified a unique molecular signature consisting of combined aberrations in TP53, PTEN and RB1 that is associated with poorer overall survival, as well as increasing prevalence of ETS gene fusions and differential gene expression patterns favoring aggressive disease and tumor progression. Identification of this subset of patients could inform prognostic decisions and provide a rationale for more aggressive or unique therapeutic approaches." @default.
- W3087202856 created "2020-09-25" @default.
- W3087202856 creator A5001794527 @default.
- W3087202856 creator A5004689576 @default.
- W3087202856 creator A5012804612 @default.
- W3087202856 creator A5014353611 @default.
- W3087202856 creator A5050241036 @default.
- W3087202856 creator A5069985314 @default.
- W3087202856 date "2020-08-15" @default.
- W3087202856 modified "2023-09-28" @default.
- W3087202856 title "Triple Aberrant Prostate Cancer (TAPC) - Aggregate role of aberrations in TP53 , PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer." @default.
- W3087202856 cites W1578291413 @default.
- W3087202856 cites W1986927943 @default.
- W3087202856 cites W1993624611 @default.
- W3087202856 cites W2013875083 @default.
- W3087202856 cites W2016371780 @default.
- W3087202856 cites W2038120654 @default.
- W3087202856 cites W2051025382 @default.
- W3087202856 cites W2070050178 @default.
- W3087202856 cites W2100739884 @default.
- W3087202856 cites W2105460321 @default.
- W3087202856 cites W2107633226 @default.
- W3087202856 cites W2121158863 @default.
- W3087202856 cites W2130410032 @default.
- W3087202856 cites W2137974207 @default.
- W3087202856 cites W2149441684 @default.
- W3087202856 cites W2161112598 @default.
- W3087202856 cites W2171825914 @default.
- W3087202856 cites W2620706965 @default.
- W3087202856 cites W2781548902 @default.
- W3087202856 cites W2789900707 @default.
- W3087202856 cites W2804412686 @default.
- W3087202856 cites W2904249129 @default.
- W3087202856 cites W2944403040 @default.
- W3087202856 cites W2997224050 @default.
- W3087202856 cites W2997243361 @default.
- W3087202856 cites W2170500510 @default.
- W3087202856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7486539" @default.
- W3087202856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32929406" @default.
- W3087202856 hasPublicationYear "2020" @default.
- W3087202856 type Work @default.
- W3087202856 sameAs 3087202856 @default.
- W3087202856 citedByCount "0" @default.
- W3087202856 crossrefType "journal-article" @default.
- W3087202856 hasAuthorship W3087202856A5001794527 @default.
- W3087202856 hasAuthorship W3087202856A5004689576 @default.
- W3087202856 hasAuthorship W3087202856A5012804612 @default.
- W3087202856 hasAuthorship W3087202856A5014353611 @default.
- W3087202856 hasAuthorship W3087202856A5050241036 @default.
- W3087202856 hasAuthorship W3087202856A5069985314 @default.
- W3087202856 hasConcept C104317684 @default.
- W3087202856 hasConcept C111829193 @default.
- W3087202856 hasConcept C121608353 @default.
- W3087202856 hasConcept C126322002 @default.
- W3087202856 hasConcept C143998085 @default.
- W3087202856 hasConcept C190283241 @default.
- W3087202856 hasConcept C2776235491 @default.
- W3087202856 hasConcept C2777609662 @default.
- W3087202856 hasConcept C2780192828 @default.
- W3087202856 hasConcept C502942594 @default.
- W3087202856 hasConcept C54355233 @default.
- W3087202856 hasConcept C71924100 @default.
- W3087202856 hasConcept C86554907 @default.
- W3087202856 hasConcept C86803240 @default.
- W3087202856 hasConceptScore W3087202856C104317684 @default.
- W3087202856 hasConceptScore W3087202856C111829193 @default.
- W3087202856 hasConceptScore W3087202856C121608353 @default.
- W3087202856 hasConceptScore W3087202856C126322002 @default.
- W3087202856 hasConceptScore W3087202856C143998085 @default.
- W3087202856 hasConceptScore W3087202856C190283241 @default.
- W3087202856 hasConceptScore W3087202856C2776235491 @default.
- W3087202856 hasConceptScore W3087202856C2777609662 @default.
- W3087202856 hasConceptScore W3087202856C2780192828 @default.
- W3087202856 hasConceptScore W3087202856C502942594 @default.
- W3087202856 hasConceptScore W3087202856C54355233 @default.
- W3087202856 hasConceptScore W3087202856C71924100 @default.
- W3087202856 hasConceptScore W3087202856C86554907 @default.
- W3087202856 hasConceptScore W3087202856C86803240 @default.
- W3087202856 hasIssue "4" @default.
- W3087202856 hasLocation W30872028561 @default.
- W3087202856 hasOpenAccess W3087202856 @default.
- W3087202856 hasPrimaryLocation W30872028561 @default.
- W3087202856 hasRelatedWork W100846060 @default.
- W3087202856 hasRelatedWork W1779829992 @default.
- W3087202856 hasRelatedWork W2014239974 @default.
- W3087202856 hasRelatedWork W2018756851 @default.
- W3087202856 hasRelatedWork W2024953281 @default.
- W3087202856 hasRelatedWork W2056261481 @default.
- W3087202856 hasRelatedWork W2089087147 @default.
- W3087202856 hasRelatedWork W2120003927 @default.
- W3087202856 hasRelatedWork W2157449758 @default.
- W3087202856 hasRelatedWork W2263302822 @default.
- W3087202856 hasRelatedWork W2325465961 @default.
- W3087202856 hasRelatedWork W2334717726 @default.
- W3087202856 hasRelatedWork W2384992413 @default.
- W3087202856 hasRelatedWork W2591305432 @default.
- W3087202856 hasRelatedWork W2888842450 @default.
- W3087202856 hasRelatedWork W2953338935 @default.